As well as PD-L1 and MSI, BRCA status is a predictive biomarker [8]: BRCA status is a well-known predictor of PARPi response and tumors with HRD show a higher tumor-infiltrating lymphocyte (TIL) infiltration [7,8]. The gene discussed is CD274; the disease is neoplasm.